Antibacterial activity of curcumin against periodontopathic bacteria

Journal of Periodontology

Volumn 87, Issue 1, 2016, Pages 83-90

  Izui, Shusuke ^a   Sekine, Shinichi ^a   Maeda, Kazuhiko ^a   Kuboniwa, Masae ^a   Takada, Akihiko ^a   Amano, Atsuo ^a   Nagata, Hideki ^a  

^a OSAKA UNIVERSITY   (Japan)

Author keywords

Biofilms; Curcumin; Periodontal diseases; Porphyromonas gingivalis

Indexed keywords

ANTIINFECTIVE AGENT; CURCUMIN;

AGGREGATIBACTER ACTINOMYCETEMCOMITANS; PORPHYROMONAS GINGIVALIS; PREVOTELLA INTERMEDIA;

AGGREGATIBACTER ACTINOMYCETEMCOMITANS; ANTI-BACTERIAL AGENTS; CURCUMIN; PORPHYROMONAS GINGIVALIS; PREVOTELLA INTERMEDIA;

EID: 84953425785     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2015.150260     Document Type: Article

References (39)

1. Genco RJ, Borgnakke WS. Risk factors for periodontal disease. Periodontol 2000 2013;62:59-94.
2. Socransky SS, Haffajee AD, Cugini MA, Smith C, Kent RL Jr. Microbial complexes in subgingival plaque. J Clin Periodontol 1998;25:134-144.
3. Takahashi K, Fukazawa M, Motohira H, Ochiai K, Nishikawa H, Miyata T. A pilot study on antiplaque effects of mastic chewing gum in the oral cavity. J Periodontol 2003;74:501-505.
4. Nagata H, Inagaki Y, Yamamoto Y, et al. Inhibitory effects of macrocarpals on the biological activity of Porphyromonas gingivalis and other periodontopathic bacteria. Oral Microbiol Immunol 2006;21:159-163.
5. Nagata H, Inagaki Y, Tanaka M, et al. Effect of eucalyptus extract chewing gum on periodontal health: A double-masked, randomized trial. J Periodontol 2008;79:1378-1385.
6. Jurenka JS. Anti-inflammatory properties of curcumin, a major constituent of Curcuma longa: A review of preclinical and clinical research. Altern Med Rev 2009;14:141-153.
7. Ammon HP, Safayhi H, Mack T, Sabieraj J. Mechanism of antiinflammatory actions of curcumine and boswellic acids. J Ethnopharmacol 1993;38:113-119.
8. Chainani-Wu N. Safety and anti-inflammatory activity of curcumin: A component of tumeric (Curcuma longa). J Altern Complement Med 2003;9:161-168.
9. Ramirez-Bosca A, Carrion-Gutierrez MA, Soler A, et al. Effects of the antioxidant turmeric on lipoprotein peroxides: Implications for the prevention of atherosclerosis. Age (Omaha) 1997;20:165-168.
10. Sugiyama Y, Kawakishi S, Osawa T. Involvementof the β-diketone moiety in the antioxidative mechanism of tetrahydrocurcumin. Biochem Pharmacol 1996;52:519-525.
11. Ruby AJ, Kuttan G, Babu KD, Rajasekharan KN, Kuttan R. Anti-tumour and antioxidant activity of natural curcuminoids. Cancer Lett 1995;94:79-83.
12. Motterlini R, Foresti R, Bassi R, Green CJ. Curcumin, an antioxidant and anti-inflammatory agent, induces heme oxygenase-1 and protects endothelial cells against oxidative stress. Free Radic Biol Med 2000;28:1303-1312.
13. Aggarwal S, Takada Y, Singh S, Myers JN, Aggarwal BB. Inhibition of growth and survival of human head and neck squamous cell carcinoma cells by curcumin via modulation of nuclear factor-kappaB signaling. Int J Cancer 2004;111:679-692.
14. Lo Tempio MM, Veena MS, Steele HL, et al. Curcumin suppresses growth of head and neck squamous cell carcinoma. Clin Cancer Res 2005;11:6994-7002.
15. Duvoix A, Blasius R, Delhalle S, et al. Chemopreventive and therapeutic effects of curcumin. Cancer Lett 2005;223:181-190.
16. Moghadamtousi SZ, Kadir HA, Hassandarvish P, Tajik H, Abubakar S, Zandi K. A review on antibacterial, antiviral, and antifungal activity of curcumin. BioMed Res Int 2014;2014:186864.
17. Wachter B, Syrowatka M, Obwaller A, Walochnik J. In vitro efficacy of curcumin on Trichomonas vaginalis (in English). Wien Klin Wochenschr 2014;126(Suppl. 1):S32-S36.
18. De R, Kundu P, Swarnakar S, et al. Antimicrobial activity of curcumin against Helicobacter pylori isolates from India and during infections in mice. Antimicrob Agents Chemother 2009;53:1592-1597.
19. Khan N, Shreaz S, Bhatia R, et al. Anticandidal activity of curcumin and methyl cinnamaldehyde. Fitoterapia 2012;83:434-440.
20. Martins CVB, da Silva DL, Neres ATM, et al. Curcumin as a promising antifungal of clinical interest. J Antimicrob Chemother 2009;63:337-339.
21. Packiavathy IA, Priya S, Pandian SK, Ravi AV. Inhibition of biofilm development of uropathogens by curcumin - An anti-quorum sensing agent from Curcuma longa. Food Chem 2014;148:453-460.
22. Magesh H, Kumar A, Alam A, et al. Identification of natural compounds which inhibit biofilm formation in clinical isolates of Klebsiella pneumoniae. Indian J Exp Biol 2013;51:764-772.
23. Shahzad M, Sherry L, Rajendran R, Edwards CA, Combet E, Ramage G. Utilising polyphenols for the clinical management of Candida albicans biofilms. Int J Antimicrob Agents 2014;44:269-273.
24. Hu P, Huang P, Chen MW. Curcumin reduces Streptococcus mutans biofilm formation by inhibiting sortase A activity. Arch Oral Biol 2013;58:1343-1348.
25. Shahzad M, Millhouse E, Culshaw S, Edwards CA, Ramage G, Combet E. Selected dietary (poly) phenols inhibit periodontal pathogen growth and biofilm formation. Food Funct 2015;6:719-729.
26. Nagata H, Iwasaki M, Maeda K, et al. Identification of the binding domain of Streptococcus oralis glyceraldehyde-3-phosphate dehydrogenase for Porphyromonas gingivalis major fimbriae. Infect Immun 2009;77:5130-5138.
27. Amano A, Kuboniwa M, Nakagawa I, Akiyama S, Morisaki I, Hamada S. Prevalence of specific genotypes of Porphyromonas gingivalis fimA and periodontal health status. J Dent Res 2000;79:1664-1668.
28. Nakayama K, Kadowaki T, Okamoto K, Yamamoto K. Construction and characterization of arginine-specific cysteine proteinase (Arg-gingipain)-deficient mutants of Porphyromonas gingivalis. Evidence for significant contribution of Arg-gingipain to virulence. J Biol Chem 1995;270:23619-23626.
29. Okamoto K, Nakayama K, Kadowaki T, Abe N, Ratnayake DB, Yamamoto K. Involvement of a lysinespecific cysteine proteinase in hemoglobin adsorption and heme accumulation by Porphyromonas gingivalis. J Biol Chem 1998;273:21225-21231.
30. Okamoto M, Sugimoto A, Leung KP, Nakayama K, Kamaguchi A, Maeda N. Inhibitory effect of green tea catechins on cysteine proteinases in Porphyromonas gingivalis. Oral Microbiol Immunol 2004;19:118-120.
31. Makimura M, Hirasawa M, Kobayashi K, et al. Inhibitory effect of tea catechins on collagenase activity. J Periodontol 1993;64:630-636.
32. Okamoto M, Leung KP, Ansai T, Sugimoto A, Maeda N. Inhibitory effects of green tea catechins on protein tyrosine phosphatase in Prevotella intermedia. Oral Microbiol Immunol 2003;18:192-195.
33. Maeda K, Nagata H, Nonaka A, Kataoka K, Tanaka M, Shizukuishi S. Oral streptococcal glyceraldehyde-3-phosphate dehydrogenase mediates interaction with Porphyromonas gingivalis fimbriae. Microbes Infect 2004;6:1163-1170.
34. Maeda K, Nagata H, Yamamoto Y, et al. Glyceraldehyde-3-phosphate dehydrogenase of Streptococcus oralis functions as a coadhesin for Porphyromonas gingivalis major fimbriae. Infect Immun 2004;72:1341-1348.
35. Sakanaka S, Aizawa M, Kim M, Yamamoto T. Inhibitory effects of green tea polyphenols on growth and cellular adherence of an oral bacterium, Porphyromonas gingivalis. Biosci Biotechnol Biochem 1996;60:745-749.
36. Muglikar S, Patil KC, Shivswami S, Hegde R. Efficacy of curcumin in the treatment of chronic gingivitis: A pilot study. Oral Health Prev Dent 2013;11:81-86.
37. Bhatia M, Urolagin SS, Pentyala KB, Urolagin SB, KBM, Bhoi S. Novel therapeutic approach for the treatment of periodontitis by curcumin. J Clin Diagn Res 2014;8:ZC65-ZC69.
38. Sasidharan NK, Sreekala SR, Jacob J, Nambisan B. In vitro synergistic effect of curcumin in combination with third generation cephalosporins against bacteria associated with infectious diarrhea. BioMed Res Int 2014;2014:561456.
39. Cheng AL, Hsu CH, Lin JK, et al. Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Res 2001;21:2895-2900.